Back to Results
First PageMeta Content
Cancer treatments / Eli Lilly and Company / Platinum compounds / Benzamides / Gemcitabine / Organofluorides / Chemotherapy / Cisplatin / Response Evaluation Criteria in Solid Tumors / CHOP / Protein-bound paclitaxel / Pancreatic cancer


High complete and partial response rate in a phase Ib/II pilot trial with albumin-bound paclitaxel and gemcitabine plus cisplatin in patients with advanced pancreatic cancer Jameson GS1, Borazanci E1, Poplin E2, Barrett
Add to Reading List

Document Date: 2015-04-20 18:14:36


Open Document

File Size: 2,03 MB

Share Result on Facebook